Just two days after we reported on the design story behind the Vessix V2 renal denervation system, Vessix Vascular is now announcing it has received European CE Mark approval for its percutaneous radiofrequency balloon catheter technology for the treatment of hypertension. According to the company, the system is faster, easier to use and less painful for patients than any renal denervation system currently available on the market. The V2 is approved for use in patients with uncontrolled hypertension despite taking three or more anti-hypertensive medications. In these patients, renal denervation Read More...
Read the complete post at http://feedproxy.google.com/~r/Medgadget/~3/AVxQvLpedws/vessix-v2-renal-denervation-system-receives-ce-mark-approval.html
May 02 2012, 12:23 PM